Top Cannabis Ideas as Pot Stocks Become Deep Value Investment Theme...

0
The recession shade is casting a pall over the US equities market over recent weeks (1). More Wall Street houses are starting...

Value Builds in Select Crypto Mining Stocks (HIVE, BLQC, RIOT, MARA,...

0
Wells Fargo is now forecasting a recession in the US – the first US-based major bank to come out with that analysis...

Popular News

MAKE IT MODERN

LATEST REVIEWS

Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) And Cheisi Submit BLA for PRX-102 in...

0
Protalix BioTherapeutics Inc. (NYSEAMERICAN:PLX) and Chiesi Global Rare Diseases have announced that they have submitted a Biologics License Application to the FDA for pegunigalsidase...

MAKE IT MODERN

PERFORMANCE TRAINING

The US FDA Reclassifies Eyenovia Inc.’s (NASDAQ: EYEN) MyCombi Formulation As A Drug-Device

0
Eyenovia Inc. (NASDAQ: EYEN) has announced the reclassification of its novel first-in-class microdose formulation combination of phenylephrine and tropicamide for in-office pupil dilation, MydCombi,...

Dare Biosciences Inc. (NASDAQ:DARE) Reports Positive DARE-BV1 Study Results In Bacterial Vaginosis Treatment

0
Dare Biosciences Inc. (NASDAQ:DARE) has announced encouraging top-line DARE-BVFREE Third Phase double-blinded, randomized, placebo-controlled clinical study results. The study evaluated the company's DARE-BV1 in...

Why the EV Pullback Could be a Once-in-a-Lifetime Opportunity for Investors (TSLA, DSGT, XPEV,...

0
If there’s one stat that really shows the growth potential in the electric vehicle space over coming years, it’s this: EVs accounted...

Curis, Inc. (NASDAQ: CRIS) Recently Announced Its Partners’ Publication on Emarvusatib

0
Curis, Inc. (NASDAQ: CRIS) recently announced the publication of a report created by the company's collaborators. The school of Medicine from Washington University authored...

IDEAYA Biosciences Inc. (NASDAQ:IDYA) And GlaxoSmithKline Plc (NYSE:GSK) In Strategic Partnership For Synthetic Lethality...

0
IDEAYA Biosciences Inc. (NASDAQ:IDYA) has announced a strategic partnership with GlaxoSmithKline Plc (NYSE:GSK) in Synthetic lethality, which is an emerging Oncology field. IDEAYA’s Synthetic Lethality...

MAKE IT MODERN

POPULAR

[/tdc_zone]